MEI Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
MEI Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2020 to Q1 2024.
  • MEI Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $10.8M, a 12.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $10.8M -$1.5M -12.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $11.2M -$1.48M -11.6% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $11.6M -$1.45M -11.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $12M +$2.92M +32.2% Jun 30, 2023 10-Q 2024-05-09
Q1 2023 $12.3M +$2.81M +29.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $12.7M +$5.37M +73.4% Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $13.1M +$5.5M +72.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $9.05M +$1.28M +16.5% Jun 30, 2022 10-K 2023-09-26
Q1 2022 $9.52M +$1.53M +19.2% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $7.33M -$882K -10.7% Dec 31, 2021 10-Q/A 2022-05-23
Q3 2021 $7.55M -$869K -10.3% Sep 30, 2021 10-Q/A 2022-05-23
Q2 2021 $7.77M +$7.77M Jun 30, 2021 10-K 2022-09-08
Q1 2021 $7.99M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $8.21M Dec 31, 2020 10-Q 2021-02-04
Q3 2020 $8.42M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $0 Jun 30, 2020 10-K/A 2022-05-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.